FDA Import Refusal 8NP-0146038-9/10002/1 — Hybio Pharmaceutical Co., Ltd.
The FDA refused shipment 8NP-0146038-9/10002/1 from Hybio Pharmaceutical Co., Ltd. (China) on June 30, 2026. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charges: 118,2280,3280 This firm has 1 other import refusal on record.
Refusal Details
- Date
- June 30, 2026
- Country
- China
- Product Category
- Drugs and Biologics
- Product Code
- 61PBY72 SEMAGLUTIDE (ANTI-DIABETIC)
- Charges
- 118,2280,3280